Generate QR code
Open Access
Subscription Access
Unobvious long-term effects of COVID-19 for kidneys. The literature review
https://doi.org/10.36485/1561-6274-2024-28-2-23-30
EDN: QJXVTN
Abstract
The impact of COVID-19 on the course of chronic kidney disease (CKD) has already been confirmed by researchers around the world. Basically, studying kidney damage in COVID-19, the authors pay attention to the new coronavirus infection in terms of the development of acute kidney injury (AKI) or mortality from it in patients with existing CKD, especially patients receiving hemodialysis or having a transplanted kidney, providing an analysis of mortality, risks and forecasts. However, there is still no published description of how this infection can affect the function of kidneys that did not have signs of CKD before COVID-19. Currently, studies devoted to the analysis of long-term results of observation and treatment of such patients are especially scarce. The review examines foreign and domestic studies concerning both the influence of chronic kidney disease on the severity of coronavirus infection and the risks of developing kidney disease after COVID-19, including the development of acute kidney injury and in the long term. This approach can highlight the relevance of timely identification of patients with developing CKD in the early stages among patients with COVID-19 for the purpose of their further follow-up and timely prescription of nephroprotective therapy. The search for literature sources was carried out using PubMed, Science Direct, eLibrary using the keywords “coronavirus”, “COVID-19”, “SARS-CoV-2”, “acute kidney injury”, “chronic kidney disease” and their combinations covering publications from 2019 to 2023 in Russian and English.
About the Authors
V. A. Fedulkina
Surgical Department of Kidney Transplantation, Moscow Regional Research Clinical Institute named after. M.F. Vladimirsky
Russian Federation
Russian Federation
Senior researcher Fedulkina Veronika Andreevna, MD, PhD
129110, Russia, Moscow, st. Shchepkina, 61/2
A. A. Artamonova
Surgical Department of Kidney Transplantation, Moscow Regional Research Clinical Institute named after. M.F. Vladimirsky
Russian Federation
Russian Federation
Senior researcher Artamonova Alexandra Anatolyevna, Ph.D. n.
129110, Russia, Moscow, st. Shchepkina, 61/2
References
1. Degenaar A, Jacobs A, Kruger R et al. Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study. BMC Nephrol 2023;24(1):96. doi: 10.1186/s12882-023-03100-w
2. Major RW, Cheng MRI, Grant RA et al. Сardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One 2018;13(3):e0192895. doi: 10.1371/journal.pone.0192895
3. Tangri N, Moriyama T, Schneider MP et al. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open 2023;13(5):e067386. doi: 10.1136/bmjopen-2022-067386
4. Jager KJ, Kovesdy C, Langham R et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019;96(5):1048–1050. doi: 10.1016/j.kint.2019.07.012
5. Power A, Sultan AA, Arnlov J. Inside CKD: projecting the future burden of chronic kidney disease in Europe using microsimulation modelling [poster]. Presented at: International Society of Nephrology World Congress of Nephrology (ISN-WCN) (Virtual Meeting); April 15–19, 2021
6. Kushner P, Peach E, Wittbrodt E et al. Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEALCKD study. Clin Kidney J 2021;15(4):738–746. doi: 10.1093/ckj/sfab235
7. World Health Organization (WHO). Statistics on COVID-19 in Russian Federation. 15.08.2023 [Internet]. Available from: https://covid19.who.int/region/euro/country/ru
8. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239–1242. doi: 10.1001/jama.2020.2648
9. CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 – United States. February 12 – March 28. Weekly 2020;69(13):382–386. doi:10.15585/mmwr.mm6913e2
10. Guan WJ, Ni ZY, Hu Y et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032
11. COVID-19 Surveillance Group. Characteristics of COVID-19 patients dying in Italy: report based on available data on March 20th, 2020. Rome, Italy: Instituto Superiore Di Sanita; 2020 [Internet]. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdf
12. Tomilina NA, Frolova NF, Artyuhina LYU et al. COVID-19: relationship with kidney diseases. Literature review. Nephrology and dialysis 2021; 23(2):147–159 (In Russ.) doi: 10.28996/2618-9801-2021-2-147-159
13. Kravchenko AYa, Kontsevaya AV, Budnevsky AV, Chernik TA. Novel coronavirus infection (COVID-19) and kidney disease. Profilakticheskaya Meditsina 2022;25(3):92–97 (In Russ.) doi: 10.17116/profmed20222503192
14. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology 2020;52(6):1193–1194. doi: 10.1007/s11255-020-02451-9/
15. Suleyman G, Fadel RA, Malette KM et al. Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Network Open 2020;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270
16. Duarsa GWK, Sugianto R, Yusari IGAAA et al. Method for determining predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019 in a systematic review and meta-analysis research. MethodsX 2023;11:102250. doi: 10.1016/j.mex.2023.102250
17. Ghaffari Rahbar M, Nafar M, Khoshdel A et al. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22(5):e13406. doi: 10.1111/tid.13406
18. Caillard S, Anglicheau D, Matignon M et al. French SOT COVID Registry. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98(6):1549–1558. doi: 10.1016/j.kint.2020.08.005
19. Santeusanio AD, Menon MC, Liu C et al. Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID-19). Clin Transplant 2021;35(4):e14221. doi: 10.1111/ctr.14221
20. Zhang J, Pang Q, Zhou T et al. Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis. Ren Fail 2023;45(1):2170809. doi: 10.1080/0886022X.2023.2170809
21. Chen YT, Shao SC, Hsu CK et al. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Crit Care 2020;24(1):346. doi: 10.1186/s13054-020-03009-y
22. Sabaghian T, Kharazmi AB, Ansari A et al. COVID-19 and Acute Kidney Injury: A Systematic Review. Front Med (Lausanne) 2022;9:705908. doi: 10.3389/fmed.2022.705908
23. Zhen Li, Ming Wu, Jiwei Yao et al. Caution on Kidney Dysfunctions of COVID-19 Patients. MedRxiv preprint 2020;02.08.20021212; doi: https://doi.org/10.1101/2020.02.08.20021212
24. Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005
25. Yang Q, Yang X. Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients. PLOS One 2020;15(11):e0241953. doi: 10.1371/journal.pone.0241953
26. Pei G, Zhang Z, Peng J et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol 2020;31(6):1157–1165. doi: 10.1681/ASN.2020030276
27. Stolyarevich ES, Frolova NF, Artyuhina LYU, Varyasin VV. Kidney damage in COVID-19: clinical and morphological manifestations of renal pathology in 220 patients died from COVID-19. Nephrology and Dialysis 2020;22 (Special Issue):46–55. doi: 10.28996/2618-9801
28. Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585
29. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
30. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7
31. Diao B, Wang C, Wang R et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun 2021;12(1):2506. doi: 10.1038/s41467-021-22781-1
32. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3
33. Chen T, Wu D, Chen H et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091. doi: 10.1136/bmj.m1091
34. Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475–481. doi: 10.1016/S2213-2600(20)30079-5
35. Arentz M, Yim E, Klaff L et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020;323(16):1612–1614. doi: 10.1001/jama.2020.4326
36. Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney 360 2021;3(2):242–257. doi: 10.34067/KID.0005342021
37. Hirsch JS, Ng JH, Ross DW et al. Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020;98(1):209–218. doi: 10.1016/j.kint.2020.05.006
38. Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775
39. Hobson CE, Yavas S, Segal MS et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119(18):2444–2453. doi: 10.1161/CIRCULATIONAHA.108.800011
40. Ng JH, Hirsch JS, Hazzan A et al. Northwell Nephrology COVID-19 Research Consortium. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis 2021;77(2):204–215.e1. doi: 10.1053/j.ajkd.2020.09.002
41. Sang L, Chen S, Zheng X et al. The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med 2020;20(1):290. doi: 10.1186/s12890020-01305-5
42. Chaudhri I, Moffitt R, Taub E et al. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19. Kidney Blood Press Res 2020;45(6):1018–1032. doi: 10.1159/000511946
43. Hultström M, Lipcsey M, Wallin E et al. Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care 2021;25(1):37. doi: 10.1186/s13054-021-03461-4
44. Nugent J, Aklilu A, Yamamoto Y et al. Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19. JAMA Netw Open 2021;4(3):e211095. doi: 10.1001/jamanetworkopen.2021.1095
45. Legrand M, Bell S, Forni L et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021;17(11):751–764. doi: 10.1038/s41581-021-00452-0
46. Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005
47. Chan L, Chaudhary K, Saha A et al. On behalf of the Mount Sinai COVID Informatics Center (MSCIC). AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol 2021;32(1):151–160. doi: 10.1681/ASN.2020050615
48. Temiz MZ, Hacibey I, Yazar RO et al. Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. Ren Fail 2022;44(1):233–240. doi: 10.1080/0886022X.2022.2032743
49. Filev R, Rostaing L, Lyubomirova M et al. COVID-19 Infection in Chronic Kidney Disease Patients in Bulgaria: Risk Factors for Death and Acute Kidney Injury. J Pers Med 2022;12(10):1676. doi: 10.3390/jpm12101676
50. Oynotkinova OSh, Matskeplishvili ST, Larina VN et al. The effect of SARS-CoV-2 on multi-organ damage and rehabilitation tactics in the post-COVID period. Kardiologiya i Serdechno-Sosudistaya Khirurgiya 2022;15(2):202–214 (In Russ.) doi: 10.17116/kardio202215021202
51. Borisova OV, Makovetskaya GA, Mazur LI et al. COVID-19 pandemic and kidney disease in children: literature review and own regional observations. Meditsinskiy sovet 2022;(1):134–141 (In Russ.) doi: 10.21518/2079-701X-2022-16-1-134-141
52. Nurullina GI, Khalfina TN, Islamova et al. Clinical case of acute kidney injury in a patient with COVID-19. Practical medicine 2022;20(1):129–132 (In Russ.) doi: 10.32000/2072-1757-2022-1-129-132
53. Ivanov DD, Gozhenko AI, Ivanova MD, Zavalnaya IN. Effect of COVID-19 on kidney function in patients with arterial hypertension grade 1–2 and CKD. Nephrology (Saint-Petersburg) 2022;26(1):34–43. (In Russ.) doi: 10.36485/1561-6274-202226-1-34-43
54. Arutyunov GP, Tarlovskaya EI, Arutyunov AG et al. Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up). Russian Journal of Cardiology 2023;28(1):5270. (In Russ.) doi: 10.15829/1560-4071-2023-5270
55. Ayoubkhani D, Khunti K, Nafilyan V et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021;372:n693. doi: 10.1136/bmj.n693
56. Chaolin H, Huang C, Huang L et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397(10270):220–232. doi: 10.1016/S0140-6736(20)32656-8
57. Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney 360 2021;3(2):242–257. doi: 10.34067/KID.0005342021
58. Hudyakova AD, Kashirina AP, Karaseva AA et al. Associations of renal dysfunction and hyperuricemia in patients with a new coronavirus infection. Nephrology and dialysis 2022;24(3):486–493. (In Russ.) doi: 10.28996/2618-9801-2022-3-486-493
59. Chávez-Valencia V, Orizaga-de-la-Cruz C, LagunasRangel FA. Acute Kidney Injury in COVID-19 Patients: Pathogenesis, Clinical Characteristics, Therapy, and Mortality. Diseases 2022;10(3):53. doi: 10.3390/diseases10030053
60. Pan XW, Xu D, Zhang H et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 2020;46(6):1114–1116. doi: 10.1007/s00134-020-06026-1
61. Su L, Zhang J, Peng Z. The role of kidney injury biomarkers in COVID-19. Ren Fail 2022;44(1):1280–1288. doi: 10.1080/0886022X.2022.2107544
62. Alieva AM, Teplova NV, Reznik EV et al. Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases. Therapy 2022;8(1):50–59. (In Russ.) doi: 10.18565/therapy.2022.1.50-59
63. Garganeeva AA, Kuzheleva EA, Fediunina VA et al. Low level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with chronic heart failure and multivessel coronary atherosclerosis. Russian Open Medical Journal 2022;11:e0102. doi: 10.15275/rusomj.2022.0102
64. Malyarchikov AV, Shаpovаlov KG, Lukyanov SA et al. Acute kidney injury in patients with pneumonia with A/H1N1 influenza. Acta Biomedica Scientifica 2021;6(3):53–59. (In Russ.) doi: 10.29413/ABS.2021-6.3.5
65. Stopic B, Medic-Brkic B, Savic-Vujovic K et al. Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease. Dose Response 2022;20(3):15593258221127568. doi: 10.1177/15593258221127568
66. Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol 2021;17(2):81–82. doi: 10.1038/s41581-020-00381-4
Review
For citations:
Fedulkina V.A., Artamonova A.A. Unobvious long-term effects of COVID-19 for kidneys. The literature review. Nephrology (Saint-Petersburg). 2024;28(2):23-30. (In Russ.) https://doi.org/10.36485/1561-6274-2024-28-2-23-30. EDN: QJXVTN
Views:
359
Email this article 